# DC Vaccine in Pancreatic Cancer

> **NCT03592888** · PHASE1 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 29 (actual)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma

## Interventions

- **DRUG:** mDC3/8-KRAS Vaccine

## Key facts

- **NCT ID:** NCT03592888
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-20
- **Primary completion:** 2024-02-12
- **Final completion:** 2024-02-12
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2025-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03592888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03592888, "DC Vaccine in Pancreatic Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03592888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*